top of page

All Posts


StimSense at the 3rd Expert Summit on the Future of DBS, Würzburg, Germany,
SERG Technology is developing StimSense, an intelligent algorithm that estimates Parkinsonian symptom severity from wearable sensor data. When combined with algorithmic search software, we demonstrated that StimSense can automate parts of and accelerate DBS programming. We recently showcased our study at the 3rd Expert Summit on the Future of DBS ( https://dbs-expertsummit.de/ ) in Würzburg, Germany. Our results show that: StimSense predictions correlated well with clinician
Diana Darko
Mar 91 min read


Understanding Deep Brain Stimulation (DBS) for Parkinson’s
Deep Brain Stimulation (DBS) for Parkinson’s: What Is It? Deep Brain Stimulation (DBS) is an advanced treatment option for Parkinson’s. In addition to movement disorders, DBS can also help manage severe cases of obsessive-compulsive disorder (OCD) and certain types of epilepsy. This article explores DBS as a treatment for managing Parkinson’s. Read on and learn how DBS works, the Parkinson’s symptoms it addresses, who it’s for, and the long-term outcomes of treating Parkinson
Diana Darko
Feb 234 min read


Understanding Deep Brain Stimulation and the Role of SERG in Treatment
An established and effective therapy for people with Parkinson's - but we believe it can be improved Deep Brain Stimulation (DBS) is a...

Samuel Wilson
Jun 21, 20253 min read


Incidence of Parkinson’s Disease in 2025
Analysing the Numbers: Parkinson’s Incidence and Prevalence Rates in 2025 In October 2025, Parkinson’s UK published a new study in the Movement Disorders Clinical Practice journal. The study looks into the incidence and prevalence rates of Parkinson’s and seven other Parkinsonism disorders in the UK. Researchers analysed population-based data in the Clinical Practice Research Datalink (CPRD) Gold and Aurum from 2003 to 2023. This is the largest study of its kind, both in sca
Diana Darko
Feb 234 min read


Parkinson's Monitoring: Why Is It So Far Behind
Parkinson’s Disease is the fastest-growing neurological condition in the world. Currently, around 166,000 people in the UK live with Parkinson’s, and that number is expected to reach 173,000 in 2030. Yet despite its prevalence and morbidity, there are huge gaps in patient care, particularly when it comes to monitoring. Compared to other lifelong conditions like Diabetes, Parkinson’s monitoring seems decades behind. Why is this the case, and what’s being done about it? Why Is
Diana Darko
Feb 234 min read


Where Real-Time Data Fits in the Future of Deep Brain Stimulation
Deep Brain Stimulation (DBS) has been transformative for people with movement disorders such as Parkinson's, providing substantially...

Samuel Wilson
Jul 3, 202522 min read
bottom of page